PL356990A1 - Pochodne izoksazolokarboksyamidu - Google Patents

Pochodne izoksazolokarboksyamidu

Info

Publication number
PL356990A1
PL356990A1 PL00356990A PL35699000A PL356990A1 PL 356990 A1 PL356990 A1 PL 356990A1 PL 00356990 A PL00356990 A PL 00356990A PL 35699000 A PL35699000 A PL 35699000A PL 356990 A1 PL356990 A1 PL 356990A1
Authority
PL
Poland
Prior art keywords
alpha1
receptor antagonists
adrenergic receptor
isoxazolecarboxamide
derivatives
Prior art date
Application number
PL00356990A
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Elena Poggesi
Original Assignee
Recordati S.A, Chemical And Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati S.A, Chemical And Pharmaceutical Company filed Critical Recordati S.A, Chemical And Pharmaceutical Company
Publication of PL356990A1 publication Critical patent/PL356990A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL00356990A 1999-10-18 2000-10-16 Pochodne izoksazolokarboksyamidu PL356990A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002173A IT1314191B1 (it) 1999-10-18 1999-10-18 Derivati isossazolcarbossamidici
PCT/EP2000/010144 WO2001029015A2 (en) 1999-10-18 2000-10-16 Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists

Publications (1)

Publication Number Publication Date
PL356990A1 true PL356990A1 (pl) 2004-07-12

Family

ID=11383797

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356990A PL356990A1 (pl) 1999-10-18 2000-10-16 Pochodne izoksazolokarboksyamidu

Country Status (25)

Country Link
EP (1) EP1226131B1 (pl)
JP (1) JP2003512362A (pl)
KR (1) KR20020038944A (pl)
CN (1) CN1139579C (pl)
AR (1) AR029400A1 (pl)
AT (1) ATE256670T1 (pl)
AU (1) AU757614B2 (pl)
BR (1) BR0014851A (pl)
CA (1) CA2385472A1 (pl)
DE (1) DE60007347T2 (pl)
DK (1) DK1226131T3 (pl)
ES (1) ES2210033T3 (pl)
HK (1) HK1044940A1 (pl)
HU (1) HUP0203184A3 (pl)
IL (1) IL148837A0 (pl)
IT (1) IT1314191B1 (pl)
MX (1) MXPA02003432A (pl)
MY (1) MY120400A (pl)
NO (1) NO20021803L (pl)
NZ (1) NZ517884A (pl)
PL (1) PL356990A1 (pl)
PT (1) PT1226131E (pl)
RU (1) RU2002113096A (pl)
WO (1) WO2001029015A2 (pl)
ZA (1) ZA200203942B (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006301376A1 (en) 2005-10-11 2007-04-19 F. Hoffmann-La Roche Ag Isoxazole derivatives
BRPI0618383A2 (pt) 2005-11-09 2011-08-30 Hoffmann La Roche derivados de 3-aril-isoxazol-4-carbonil-benzofurano
RU2426731C2 (ru) 2005-12-23 2011-08-20 Ф. Хоффманн-Ля Рош Аг Производные арил-изоксазоло-4-ил-оксадиазола
DK1968973T3 (da) 2005-12-27 2011-10-31 Hoffmann La Roche Aryl-isoxazol-4-yl-imidazolderivater
AU2007207053B2 (en) 2006-01-17 2012-05-24 F. Hoffmann-La Roche Ag Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of Alzheimer's disease via GABA receptors
ES2328185T3 (es) 2006-05-31 2009-11-10 F. Hoffmann-La Roche Ag Derivados de aril-4-etinil-isoxazol.
ES2369805T3 (es) 2007-06-22 2011-12-07 F. Hoffmann-La Roche Ag Derivados de isoxazol-imidazol.
CN101883769B (zh) 2007-12-04 2012-08-08 弗·哈夫曼-拉罗切有限公司 异噁唑-吡嗪衍生物
US7902201B2 (en) 2007-12-04 2011-03-08 Hoffmann-La Roche Inc. Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
TW201033201A (en) 2009-02-19 2010-09-16 Hoffmann La Roche Isoxazole-isoxazole and isoxazole-isothiazole derivatives
US8389550B2 (en) 2009-02-25 2013-03-05 Hoffmann-La Roche Inc. Isoxazoles / O-pyridines with ethyl and ethenyl linker
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
US20100280019A1 (en) 2009-04-30 2010-11-04 Roland Jakob-Roetne Isoxazoles
EP2427458B1 (en) 2009-05-05 2014-05-07 F.Hoffmann-La Roche Ag Isoxazole-pyridazine derivatives
CA2760166C (en) 2009-05-05 2017-07-18 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives
MX2011011490A (es) 2009-05-05 2011-11-18 Hoffmann La Roche Derivados de isoxazol-tiazol como agonistas inversos del receptor de acido gamma-aminobutirico a (gaba a), para usarse en el tratamiento de trastornos cognitivos.
KR101384829B1 (ko) 2009-05-05 2014-04-15 에프. 호프만-라 로슈 아게 이속사졸-피라졸 유도체
WO2010127978A1 (en) 2009-05-07 2010-11-11 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives as gaba modulators
US8785435B2 (en) 2011-10-20 2014-07-22 Hoffmann-La Roche Inc. Solid forms
CN113121540B (zh) * 2020-01-15 2024-01-26 鲁南制药集团股份有限公司 一种西格列汀游离碱的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen

Also Published As

Publication number Publication date
IL148837A0 (en) 2002-09-12
EP1226131B1 (en) 2003-12-17
AU2834701A (en) 2001-04-30
ATE256670T1 (de) 2004-01-15
BR0014851A (pt) 2002-06-11
RU2002113096A (ru) 2003-11-10
ZA200203942B (en) 2003-01-02
DK1226131T3 (da) 2004-04-19
NO20021803D0 (no) 2002-04-17
CA2385472A1 (en) 2001-04-26
WO2001029015A2 (en) 2001-04-26
NO20021803L (no) 2002-06-17
CN1139579C (zh) 2004-02-25
AU757614B2 (en) 2003-02-27
EP1226131A2 (en) 2002-07-31
IT1314191B1 (it) 2002-12-06
MY120400A (en) 2005-10-31
WO2001029015A3 (en) 2001-11-01
ITMI992173A0 (it) 1999-10-18
JP2003512362A (ja) 2003-04-02
DE60007347D1 (de) 2004-01-29
NZ517884A (en) 2003-08-29
ITMI992173A1 (it) 2001-04-18
DE60007347T2 (de) 2004-09-02
ES2210033T3 (es) 2004-07-01
HUP0203184A3 (en) 2004-12-28
CN1379767A (zh) 2002-11-13
KR20020038944A (ko) 2002-05-24
MXPA02003432A (es) 2002-08-20
AR029400A1 (es) 2003-06-25
HUP0203184A2 (hu) 2003-01-28
PT1226131E (pt) 2004-05-31
HK1044940A1 (zh) 2002-11-08

Similar Documents

Publication Publication Date Title
HK1076459A1 (en) 4-Phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
PL357433A1 (pl) Pochodne benzodiazepiny
PL357418A1 (pl) Pochodne benzodiazepiny
EP1206262A4 (en) Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES
PL356990A1 (pl) Pochodne izoksazolokarboksyamidu
EP1194151A4 (en) ANTAGONISTS OF THE INTEGRIN RECEPTORS
EP1229910A4 (en) integrin
IL153837A0 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
HUP0201524A2 (en) Bradykinin receptor antagonists
IL148623A0 (en) Thienoisoxazolyl-and thienylpyrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
EP1248607A4 (en) UROTENSIN II RECEPTOR ANTAGONISTS
IL146151A0 (en) Human-g-protein receptor
IL145166A0 (en) Biphenyl derivatives as antagonists of the neurokinine-1 receptor
IL144299A0 (en) N-triazolymethyl-piperazine derivatives as neurokinin receptor antagonists
IL148043A0 (en) Novel integrin receptor antagonists
GC0000203A (en) Vitronectin receptor antagonists
IL146146A0 (en) Integrin receptor antagonists
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU2574801A (en) Selective iGLUR5 receptor antagonists
EP1169042A4 (en) DIBENZO-AZEPINE DERIVATIVES AS ANTAGONISTS OF THE ALPHA V INTEGRIN RECEPTOR
GB0026327D0 (en) Thrombin receptor antagonists
AU2512800A (en) Alpha1-adrenergic receptor antagonists
HK1043988A1 (zh) 作為黃體酮拮抗劑的二氫吲衍生物
GB9923910D0 (en) Prolactin receptor
GB9811283D0 (en) Vironectin receptor antagonists

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)